Skip to main content
. 2014 Dec 30;6(5):2827–2842. doi: 10.18632/oncotarget.3090

Figure 3. Inhibitory effect of five DOX-containing formulations on the proliferation of MCF-7 cells.

Figure 3

(A) and MCF-7/Adr cells (B) in vitro. The data are presented as the mean ± SD (n=3). Notes: aP<0.05, compared with free DOX; bP<0.05, compared with DOX·HCL; cP<0.05, compared with DOX nanoparticles; dP<0.05, compared with targeted DOX nanoparticles.